Organogenesis Holdings Inc. logo

Organogenesis Holdings Inc. (ORGO)

Market Closed
10 Sep, 20:00
NASDAQ (CM) NASDAQ (CM)
$
1. 53
-0.04
-2.5478%
Pre Market
$
1. 60
+0.07 +4.5752%
220.03M Market Cap
38.7 P/E Ratio
- Div Yield
912,468 Volume
0.07 Eps
$ 1.57
Previous Close
Add Transaction
Day Range
1.49 1.57
Year Range
1.49 7.08
Want to track ORGO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Organogenesis Holdings Inc. (ORGO) Statistics

Valuation metrics

Market Cap 220.03M
Enterprise value 240.89M
Trailing P/E (ttm) -2.09
Forward P/E 8.31
PEG ratio -0
Price/Sales (ttm) 0.48
Price/Book (mrq) 0.76
Enterprise Value/Revenue 0.53
Enterprise Value/EBITDA -50.95

Overview

Shares outstanding 126.95M
Float 57.98M
Shares short 12.79M
% Held by insiders 0.48%
% Held by institutions 0.52%
Average volume (10 days) 665.5K
Average volume (90 days) 915K

Price summary

52-Week low 1.49
52-Week high 7.08
Beta 1.48
50-Day moving average 2.16
200-Day moving average 2.62

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025

Profitability

Profit margin -0.2%
Operating margin -0.06%

Operational effectiveness

Return on assets -0.22%
Return on equity -0.24%

Income Statement

Revenue (ttm) 564.17M
Revenue per share (ttm) 3.55
Quarterly revenue growth (yoy) 0.78%
Gross profit (ttm) 426.65M
EBITDA 93.98M
Net income to common (ttm) 20.02M
Diluted EPS (ttm) -0.7
Quarterly earnings growth (yoy) 4.7%

Balance Sheet

Total cash (mrq) 95.92M
Total cash per share (mrq) 0.36
Total debt (mrq) 82.14M
Total Debt/Equity (mrq) 0.23
Current ratio (mrq) 3.52%
Book value per share (mrq) 2.24

Cash Flow

Cash flow statement -10.31M
Levered free cash flow (LFCF) -50.1M